AbbVie, Roche, Regeneron could significantly benefit as AMD market expected to soar
Seeking Alpha· 2 days agoAbbVie (NYSE:ABBV), Roche (OTCQX:RHHBY), and Regeneron Pharmaceuticals (NASDAQ:REGN), which market...
Opthea Secures up to US$170 Million in Non-Dilutive Financing for OPT-302 in wet AMD
Morningstar· 7 hours agoLaunch Tx is the recently formed development company backed by funds managed by global investment firm Carlyle (NASDAQ: CG) and its life sciences franchise, Abingworth.
Kodiak Sciences Stock: Expecting Sentiment To Turn Bullish
Seeking Alpha· 7 days agoIn February 2022, the stock of Kodiak Sciences (NASDAQ:KOD) crashed 80% as the company read out...
Kodiak Sciences (KOD) Q2 Earnings Beat, Eye Candidate in Focus
Zacks via Yahoo Finance· 5 days agoKodiak Sciences (KOD) reports narrower-than-expected loss for the second quarter of 2022. The focus...
Kodiak Sciences Announces Second Quarter 2022 Financial Results and Recent Business Highlights
Morningstar· 5 days agoKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases ...
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha· 2 weeks agoEyePoint Pharmaceuticals, Inc. (NASDAQ:NASDAQ:EYPT) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants George Elston - Chief Financial Officer Nancy Lurker -...
Yahoo Web Search
- 16 results
Trending Now
